Fernandez Ruiz, Javier - Portal de Investigación del Consorcio Madroño

Murineddu G, Deligia F, Ragusa G, García-Toscano L, Gómez-Cañas M, Asproni B, Satta V, Cichero E, Pazos R, Fossa P, Loriga G, Fernández-Ruiz J, Pinna GA

BIOORGANIC & MEDICINAL CHEMISTRY (p. 295-307) - 1/1/2018

10.1016/j.bmc.2017.11.051

ISSN 14643391

iMarina

Este/a investigador/a no tiene libros.

Cannabinoids and the brain: New hopes for new therapies

Fernández-Ruiz J
Hernández M
García-Movellán Y

Cannabinoids (p. 175-218) - 11/8/2014

10.1002/9781118451281.ch6 Ver en origen

iMarina

The endocannabinoid system in the physiology and pathology of the basal ganglia

Gerdeman G
Fernández-Ruiz J

Cannabinoids and the Brain (p. 423-483) - 1/1/2008

10.1007/978-0-387-74349-3_21 Ver en origen

iMarina

Endocannabinoids and amyotrophic lateral sclerosis

de Lago E
Moreno-Martet M
Espejo-Porras F
Fernández-Ruiz J

Cannabinoids in Neurologic and Mental Disease (p. 99-123) - 21/1/2015

10.1016/b978-0-12-417041-4.00005-9 Ver en origen

iMarina

La protección de menores en la Policía Municipal de Madrid

Javier Fernández Ruiz

El derecho a la protección de los niños y niñas en la Comunidad de Madrid (p. 171-180) - 1/1/2010

iMarina

Endocannabinoids and Neurodegenerative disorders: Parkinson’s disease, Huntington’s chorea, Alzheimer’s disease, and others

Fernández-Ruiz J
Romero J
Ramos J

Handbook of Experimental Pharmacology (p. 233-259) - 29/9/2015

10.1007/978-3-319-20825-1_8 Ver en origen

ISSN 01712004

iMarina

The service of Minors' Guardian Officers in Madrid Municipal Police

Javier Fernández Ruiz

Memoria Del Congreso International Sobre Seguridad Ciudadana En La Sociedad Diversa: 19 A 22 De Octubre De 2011 (p. 370-371) - 1/1/2011

iMarina

Modeling Neurodegenerative Disorders for Developing Cannabinoid-Based Neuroprotective Therapies

Fernández-Ruiz J
Gómez-Ruiz M
García C
Hernández M
Ramos JA

Methods In Enzymology (p. 175-198) - 1/1/2017

10.1016/bs.mie.2017.06.021 Ver en origen

ISSN 00766879

iMarina

Endocannabinoid-Binding Receptors as Drug Targets

Gómez-Cañas M
Rodríguez-Cueto C
Satta V
Hernández-Fisac I
Navarro E
Fernández-Ruiz J

Methods In Molecular Biology (p. 67-94) - 1/1/2023

10.1007/978-1-0716-2728-0_6 Ver en origen

ISSN 10643745

iMarina

Chapter 2: Phytocannabinoids Versus Endocannabinoids. A Modern View of the Endocannabinoid System

Fernández-Ruiz J
Sagredo O
De Lago E

RSC Drug Discovery Series (p. 10-47) - 1/1/2021

10.1039/9781839160752-00010 Ver en origen

ISSN 20413203

iMarina

Sativex-like combination of phytocannabinoids is neuroprotective in malonate-lesioned rats, an inflammatory model of Huntington's disease: Role of CB1 and CB2 receptors

Valdeolivas S
Satta V
Pertwee R
Fernández-Ruiz J
Sagredo O

ACS Chemical Neuroscience (p. 400-406) - 16/5/2012

10.1021/cn200114w Ver en origen

ISSN 19487193

iMarina

Prenatal exposure to methamphetamine in the rat: Ontogeny of tyrosine hydroxylase mRNA expression in mesencephalic dopaminergic neurons

Gomes-Da-Silva J
Pérez-Rosado A
De Miguel R
Fernández-Ruiz J
Silva MC
Tavares MA

Annals of the New York Academy of Sciences (p. 68-77) - 1/1/2002

ISSN 00778923

iMarina

Effects of neonatal exposure to methamphetamine: Catecholamine levels in brain areas of the developing rat

Gomes-Da-Silva J
De Miguel R
Fernández-Ruiz J
Summavielle T
Tavares M

Annals of the New York Academy of Sciences (p. 602-611) - 1/1/2004

10.1196/annals.1316.075 Ver en origen

ISSN 00778923

iMarina

Design, synthesis and biological evaluation of new endocannabinoid transporter inhibitors

López-Rodríguez ML
Viso A
Ortega-Gutiérrez S
Fowler CJ
Tiger G
De Lago E
Fernández-Ruiz J
Ramos JA

... Ver más Contraer

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (p. 403-412) - 1/4/2003

10.1016/s0223-5234(03)00045-x Ver en origen

ISSN 02235234

iMarina

Role of endocannabinoids in brain development

Fernandez-Ruiz, JJ
Berrendero, F
Hernandez, ML
Romero, J
Ramos, JA

Life Sciences (p. 725-736) - 9/7/1999

10.1016/s0024-3205(99)00295-7 Ver en origen

ISSN 00243205

iMarina

Preface: Cannabinoids as new tools for the treatment of neurological disorders

Fernández-Ruiz J
Guzmán M
Ramos J

MOLECULAR NEUROBIOLOGY (p. 1-2) - 1/1/2007

10.1007/s12035-007-8005-9 Ver en origen

ISSN 08937648

iMarina

Pharmacology, Biochemistry and Behavior: Editorial

Fernandez-Ruiz J

PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (p. 221-223) - 1/1/2005

10.1016/j.pbb.2005.03.021 Ver en origen

ISSN 00913057

iMarina

Cannabinoid tolerance and dependence: A review of studies in laboratory animals

González S
Cebeira M
Fernández-Ruiz J

PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (p. 300-318) - 1/1/2005

10.1016/j.pbb.2005.01.028 Ver en origen

ISSN 00913057

iMarina

Evaluación del aprendizaje en Educación Secundaria: Concepciones y prácticas

Fernández Ruiz, J. & Panadero, E

23/6/2018

iMarina

Learning Assessment in Secondary Education: Conceptions and practices

Fernández Ruiz, J. & Panadero, E

2/7/2018

iMarina

Este/a investigador/a no tiene documentos de trabajo.

Este/a investigador/a no tiene informes técnicos.

Este/a investigador/a no tiene proyectos de investigación.

Este/a investigador/a no tiene tesis dirigidas.

Este/a investigador/a no tiene patentes o licencias de software.

Grupos de investigación

Education, Regulated Learning And Assessment
Rol: Miembro

Perfiles de investigador/a

ORCID
- 0000-0001-5419-7687
Scopus Author ID
- 7006533053
Dialnet id
- 888678

Última actualización de los datos: 18/03/24 23:57

Fernandez Ruiz, Javier javier.fernandezr@uam.es

Actividades

Preface: Why a Special Issue on cannabinoid research in Spain?

Effects of anandamide on hepatic fatty acid metabolism

Possible role of the cytochrome P450-linked monooxygenase system in preventing δ9-tetrahydrocannabinol-induced stimulation of tuberoinfundibular dopaminergic activity in female rats

Neuroprotective effects of the cannabigerol quinone derivative VCE-003.2 in SOD1G93A transgenic mice, an experimental model of amyotrophic lateral sclerosis

Time course of the effects of different cannabimimetics on prolactin and gonadotrophin secretion: Evidence for the presence of CB 1 receptors in hypothalamic structures and their involvement in the effects of cannabimimetics

Effect of repeated systemic administration of selective inhibitors of endocannabinoid inactivation on rat brain endocannabinoid levels

Effects of cannabinoids on prolactin and gonadotrophin secretion: Involvement of changes in hypothalamic γ-aminobutyric acid (GABA) inputs

Changes in cannabinoid receptor binding and mRNA levels in several brain regions of aged rats

Prolonged effects of persistent hyperprolactinemia on adrenal medullary function in male rats

Novel sulfenamides and sulfonamides based on pyridazinone and pyridazine scaffolds as CB1 receptor ligand antagonists.